Cell and Gene Therapy Train-the-Trainer Session 2
Event Details
Recent
- Mon, Jan 24 2022, 10:30am - 12:30pm EST
Event Description
Cell-based and gene therapy products are a growing area and becoming a major component of the biotechnology industry. The Workforce Expansion in Biomanufacturing Emerging Technologies (WEBET) project, funded by NIIMBL, brings six InnovATEBIO college programs and their regional industry partners together to identify the technical skills and knowledge needed for the development, manufacture, and testing of these advanced therapies.
This Train the Trainer session focuses on the QC analytics, microbiological control approaches and regulatory requirements associated with manufacturing cell and gene therapy products. The equipment necessary for developing a training program will be outlined and newly developed lab-based curriculum will be presented.
It may be helpful to review material from the first Cell and Gene Therapy Train the Trainer workshop.
Event Presentations
Hands-on Curriculum, Analytics, and Equipment for Cell and Gene Therapy
Hands-on Curriculum, Analytics, and Equipment for Cell and Gene Therapy
Hands-on Curriculum Analytics
- Analytics for AAV transduction Dominique Ingato and Margaret Bryans
- Analytics for AAV production Isso Bayala
Equipment necessary to train Cell and Gene therapy technicians Barbara Juncosa
Regulatory considerations for Cell and Gene Therapies
Regulatory considerations for Cell and Gene Therapies - Jim DeKloe
Cell and Gene Therapy skill standards, analytics, and microbiological control
- Welcome and introductions - Russ Read
- New learning module for Cell and Gene Therapy - John Cumbers, Built with Biology, LalTal
- Update on cell and Gene therapy skill standards - Margaret Bryans and Jim DeKloe
- Cell and Gene therapy analytics and microbiological control - Jim DeKloe and Margaret Bryans